Design of in situ porcine closed-circuit system for assessing blood-contacting biomaterials

  • Maria Chiara Munisso
  • Atsushi Mahara
  • Tetsuji Yamaoka
Original Article Biomaterials
  • 29 Downloads

Abstract

The overall pre-clinical process of determining the blood compatibility of any medical device involves several stages. Although the primary purpose is to protect the patients, laboratory testing has been over-utilized for many years with a huge number of unnecessary animal tests being done routinely. Recently, the elimination of needless testing has become important in controlling the cost of healthcare and in addressing many issues related to the ethics of animal research. With this in mind, we designed a new in situ porcine closed-circuit system to study the complex interplay between platelets, coagulation proteins, and other cellular elements in pigs. We proved that this system can be implemented in blood compatibility testing and minimize the number of animals used in the experiments.

Keywords

ePTFE Artificial grafts Hemocompatibility 

Notes

Acknowledgements

We gratefully acknowledge the financial support of the S-innovation Research Program for the “Development of the biofunctional materials for realization of innovative medicine”, Japan Agency for Medical Research and Development (AMED).

Author contributions

MCM: conception and design, data collection, data analyses and interpretation, animal experiments, and manuscript writing. AM: animal experiments. TY: conception and design, data interpretation, and manuscript correction.

Supplementary material

10047_2018_1042_MOESM1_ESM.pdf (233 kb)
Supplementary material 1 (PDF 232 KB)

References

  1. 1.
    Voorhees AB Jr, Jaretzki A 3rd, Blakemore AH. The use of tubes constructed from vinyon “n” cloth in bridging arterial defects. Ann Surg. 1952;135:332–6.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Chlupác J, Filová E, Bačáková L. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiol Res. 2009;58:119–39.Google Scholar
  3. 3.
    Zilla P, Bezuidenhout D, Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials. 2007;28:5009–27.CrossRefPubMedGoogle Scholar
  4. 4.
    Kakisis JD, Liapis CD, Breuer C, Sumpio BE. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J Vasc Surg. 2005;41:349–54.CrossRefPubMedGoogle Scholar
  5. 5.
    Pashneh-Tala S, MacNeil S, Claeyssens F. The tissue-engineered vascular graft—past, present, and future. Tissue Eng Part B Rev. 2016;22(1):68–100.Google Scholar
  6. 6.
    Anderson DEJ, Glynn JJ, Song HK, Hinds MT. Engineering an endothelialized vascular graft: a rational approach to study design in a non-human primate model. PLoS One. 2014;9:1–23.Google Scholar
  7. 7.
    Byrom MJ, Bannon PG, White GH, Ng MKC. Animal models for the assessment of novel vascular conduits. J Vasc Surg. 2010;52:176–95.CrossRefPubMedGoogle Scholar
  8. 8.
    Ratner BD. Blood compatibility—a perspective. J Biomater Sci Polym Ed. 2000;11:1107–19.CrossRefPubMedGoogle Scholar
  9. 9.
    Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (eds). PART III: practical aspects of biomaterials implants & devices—special concerns. In: Biomaterials science: an introduction to materials in medicine. 2nd ed. Elsevier Academic Press; 2004.Google Scholar
  10. 10.
    Greek R. A discussion of the role of complex evolved systems in the development of invasive cardiovascular interventions as illustrated by the Blalock-taussig shunt and intra-arterial stents. Biol Syst. 2014;3:1–27.CrossRefGoogle Scholar
  11. 11.
    Jung F, Braune S, Lendlein A. Haemocompatibility testing of biomaterials using human platelets. Clin Hemorheol Microcirc. 2013;53:97–115.PubMedGoogle Scholar
  12. 12.
    Noishiki Y. in vivo evaluation method of a new antithrombogenicity using the peripheral vein. J Bioact Compat Polym. 1986;1:147–61.CrossRefGoogle Scholar
  13. 13.
    Silver JH, Hergenrother RW, Lin J-C, Lim F, Lin H-B, Okada T, et al. Surface and blood-contacting properties of alkylsiloxane monolayers supported on silicone rubber. J Biomed Mater Res. 1995;29:535–48.CrossRefPubMedGoogle Scholar
  14. 14.
    Badimon L, Vilahur G, Padro T. Atherosclerosis and thrombosis: insights from large animal models. J Biomed Biotechnol. 2011;2011:1–13.Google Scholar
  15. 15.
    Munisso MC, Yamaoka T. Novel peptides for small-caliber graft functionalization selected by a phage display of endothelial-positive/platelet-negative combined selection. J Mater Chem B. 2017;5:9354–64.CrossRefGoogle Scholar
  16. 16.
    Leitão AF, Gupta S, Pedro J, Reviakine I, Gama M. Hemocompatibility study of a bacterial cellulose/polyvinyl alcohol nanocomposite. Colloids Surf B Biointerfaces. 2013;111:493–502.CrossRefPubMedGoogle Scholar
  17. 17.
    Motlagh D, Yang J, Lui KY, Webb AR, Ameer GA. Hemocompatibility evaluation of poly (glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials. 2006;27:4315–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Noe DA, Weedn V, Bell WR. Direct spectrophotometry of serum hemoglobin: an Allen correction compared with a three-wavelength polychromatic analysis. Clin Chem. 1984;30:627–30.PubMedGoogle Scholar
  19. 19.
    Cookson P, Sutherland J, Cardigan R. A simple spectrophotometric method for the quantification of residual haemoglobin in platelet concentrates. Vox Sang. 2004;87:264–71.CrossRefPubMedGoogle Scholar
  20. 20.
    Han V, Serrano K, Devine DV. A comparative study of common techniques used to measure haemolysis in stored red cell concentrates. Vox Sang. 2010;98:116–23.CrossRefPubMedGoogle Scholar
  21. 21.
    Mahara A, Somekawa S, Kobayashi N, Hirano Y, Kimura Y, Fujisato T, et al. Tissue-engineered acellular small diameter long-bypass grafts with neointima-inducing activity. Biomaterials. 2015;58:54–62.CrossRefPubMedGoogle Scholar
  22. 22.
    Hubbell J, Massia S, Desai N, Drumheller P. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology. 1991;9:568–72.PubMedGoogle Scholar
  23. 23.
    Massia S, Hubbell J. Vascular endothelial-cell adhesion and spreading promoted by the peptide Redv of the iiics region of plasma fibronectin is mediated by integrin alpha-4-beta-1. J Biol Chem. 1992;267:14019–26.PubMedGoogle Scholar
  24. 24.
    Merhi Y, King M, Guidoin R. Acute thrombogenicity of intact and injured natural blood conduits versus synthetic conduits: neutrophil, platelet, and fibrin(ogen) adsorption under various shear-rate conditions. J Biomed Mater Res. 1997;34:477–85.CrossRefPubMedGoogle Scholar
  25. 25.
    Tatterton M, Wilshaw S, Ingham E, Homer-Vanniasinkam S. The use of antithrombotic therapies in reducing synthetic small-diameter vascular graft thrombosis. Vasc Endovasc Surg. 2012;46:212–22.CrossRefGoogle Scholar
  26. 26.
    Lee JH, Khang G, Lee JW, Lee HB. Platelet adhesion onto chargeable functional group gradient surfaces. J Biomed Mater Res. 1998;41:304–11.CrossRefPubMedGoogle Scholar
  27. 27.
    Goodman SL. Sheep, pig, and human platelet–material interactions with model cardiovascular biomaterials. J Biomed Mater Res. 1999;45:240–50.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society for Artificial Organs 2018

Authors and Affiliations

  1. 1.Department of Biomedical EngineeringNational Cerebral and Cardiovascular Center Research InstituteSuitaJapan

Personalised recommendations